Table 2

Comparison between the groups for the first-pass effect

NO FPE
(mTICI 0–2b, n=259, 60.8%)
FPE
(mTICI 2 c–3, n=167, 39.2%)
p-valueNO mFPE
(mTICI 0–2a, n=205, 48.1%)
mFPE
(mTICI 2b–3, n=221, 51.9%)
Pt-value
Age (years), median (IQR)76 (65;83)76 (63;85)0.74576 (66;84)76 (63;84)0.723
Female gender, n (%)132 (51)87 (52.1)0.820107 (52.2)112 (50.7)0.754
NIHSS score at admission, median (IQR)16 (11;20)16 (10;19.5)0.20416 (12;20)15 (10;20)0.092
ASPECTS at admission, median (IQR)8 (7;9)9 (8;10)<0.0018 (7;9)9 (8;10)<0.001
Last time seen well (min), median (IQR)274 (165;541)231 (160;448)0.265279 (171;530)234 (155.5;472)0.164
IV tPA administered, n (%)
 None198 (76.4)115 (68.9)0.164158 (77.1)155 (70.1)0.156
 Partial dose17 (6.6)18 (10.8)12 (5.9)23 (10.4)
 Completed dose44 (17.0)34 (20.4)35 (17.1)43 (19.5)
General anesthesia, n (%)68 (26.3)62 (37.1)<0.00155 (26.8)75 (33.9)0.008
Local anesthesia, n (%)49 (18.9)45 (26.9)37 (18)57 (25.8)
Conscious sedation, n (%)142 (54.8)60 (35.9)113 (55.1)89 (40.3)
Left site occlusion, n (%)135 (52.1)90 (53.9)0.721105 (51.2)120 (54.3)0.525
Level of vessel occlusion, n (%)0.4650.299
 ICA carotid terminus49 (18.9)24 (14.4)37 (18)36 (16.3)
 MCA–M1139 (53.7)93 (55.7)117 (57.1)115 (52.0)
 MCA–M271 27.4)50 (29.9)51 (24.9)70 (31.7)
BGC approach used, n (%)147 (56.8)124 (74.3)<0.001115 (56.1)156 (70.6)0.002
Symptomatic intracranial hemorrhage, n (%)25 (12.3)6 (6.3)0.11713 (6.3)9 (4.1)0.290
NIHSS score at 24 hours, median (IQR)11(4;18)3 (1;7.75)<0.00112(5;19)3.5 (1;8)<0.001
Difference of NIHSS from admission to 24 hours, median (IQR)4 (0;10)10(4;15)<0.0013 (-1;9)9 (4;13.75)<0.001
mRS score 0–2 at 3 months, n (%)73 (47.1)62 (70.5)<0.00154 (42.5)81 (72.3)<0.001
Mortality, n (%)46 (29.7)10 (11.9)0.00240 (31.5)16 (14.3)0.002
  • ASPECTS, Alberta Stroke Program Early CT Score; BGC, balloon guide catheter; FPE, first-pass effect; IQR, interquartile range; mRS, modified Rankin Scale; mTICI, modified Thrombolysis in Cerebral Infarction; NIHSS, National Institutes of Health Stroke Scale.